172 related articles for article (PubMed ID: 19758163)
1. IL-10 production by B cells expressing CD5 with the alternative exon 1B.
Garaud S; Le Dantec C; de Mendoza AR; Mageed RA; Youinou P; Renaudineau Y
Ann N Y Acad Sci; 2009 Sep; 1173():280-5. PubMed ID: 19758163
[TBL] [Abstract][Full Text] [Related]
2. CD5 promotes IL-10 production in chronic lymphocytic leukemia B cells through STAT3 and NFAT2 activation.
Garaud S; Morva A; Lemoine S; Hillion S; Bordron A; Pers JO; Berthou C; Mageed RA; Renaudineau Y; Youinou P
J Immunol; 2011 Apr; 186(8):4835-44. PubMed ID: 21398617
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the human CD5 endogenous retrovirus-E in B lymphocytes.
Renaudineau Y; Vallet S; Le Dantec C; Hillion S; Saraux A; Youinou P
Genes Immun; 2005 Dec; 6(8):663-71. PubMed ID: 16107871
[TBL] [Abstract][Full Text] [Related]
4. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation.
Garaud S; Le Dantec C; Jousse-Joulin S; Hanrotel-Saliou C; Saraux A; Mageed RA; Youinou P; Renaudineau Y
J Immunol; 2009 May; 182(9):5623-32. PubMed ID: 19380809
[TBL] [Abstract][Full Text] [Related]
5. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.
Van de Velde H; von Hoegen I; Luo W; Parnes JR; Thielemans K
Nature; 1991 Jun; 351(6328):662-5. PubMed ID: 1711157
[TBL] [Abstract][Full Text] [Related]
6. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72).
Luo W; Van de Velde H; von Hoegen I; Parnes JR; Thielemans K
J Immunol; 1992 Mar; 148(6):1630-4. PubMed ID: 1371783
[TBL] [Abstract][Full Text] [Related]
7. MRC OX19 recognizes the rat CD5 surface glycoprotein, but does not provide evidence for a population of CD5bright B cells.
Vermeer LA; de Boer NK; Bucci C; Bos NA; Kroese FG; Alberti S
Eur J Immunol; 1994 Mar; 24(3):585-92. PubMed ID: 7510236
[TBL] [Abstract][Full Text] [Related]
8. An alternative exon 1 of the CD5 gene regulates CD5 expression in human B lymphocytes.
Renaudineau Y; Hillion S; Saraux A; Mageed RA; Youinou P
Blood; 2005 Oct; 106(8):2781-9. PubMed ID: 15998834
[TBL] [Abstract][Full Text] [Related]
9. Modulation of the expression of CD5 antigen on the surface of human peripheral B lymphocytes.
Kawamura M; Wheeler CJ; Notkins AL; Bich-Thuy LT
Cell Immunol; 1994 Nov; 159(1):61-76. PubMed ID: 7525082
[TBL] [Abstract][Full Text] [Related]
10. Role of IL-10 in the distribution of B cell subsets in the mouse B-1 cell population.
Pers JO; Jamin C; Youinou P; Charreire J
Eur Cytokine Netw; 2003; 14(3):178-85. PubMed ID: 14656694
[TBL] [Abstract][Full Text] [Related]
11. Fusion of hC3d3 to hCGbeta enhances responsiveness in vitro of human peripheral immunocompetent cells upon the antigen primary challenge.
Li HP; He XJ; Tang CL; Yao XY; Li DJ
J Reprod Immunol; 2008 Jul; 78(2):115-24. PubMed ID: 18479753
[TBL] [Abstract][Full Text] [Related]
12. A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing.
Hernández-Caselles T; Martínez-Esparza M; Pérez-Oliva AB; Quintanilla-Cecconi AM; García-Alonso A; Alvarez-López DM; García-Peñarrubia P
J Leukoc Biol; 2006 Jan; 79(1):46-58. PubMed ID: 16380601
[TBL] [Abstract][Full Text] [Related]
13. Native soluble CD5 delivers a costimulatory signal to resting human B lymphocytes.
Van de Velde H; Thielemans K
Cell Immunol; 1996 Aug; 172(1):84-91. PubMed ID: 8806810
[TBL] [Abstract][Full Text] [Related]
14. CD5+ B cells with the features of subepithelial B cells found in human tonsils.
Dono M; Burgio VL; Colombo M; Sciacchitano S; Reverberi D; Tarantino V; Cutrona G; Chiorazzi N; Ferrarini M
Eur J Immunol; 2007 Aug; 37(8):2138-47. PubMed ID: 17615580
[TBL] [Abstract][Full Text] [Related]
15. A chimeric proinsulin-CD5 protein expressed in AtT-20 cells is directed to the cell surface via the constitutive pathway.
Mbikay M; Grondin G; Rondeau N; Talbot BG; Chrétien M
Exp Cell Res; 1995 Sep; 220(1):79-91. PubMed ID: 7545131
[TBL] [Abstract][Full Text] [Related]
16. Human Soluble CD80 is generated by alternative splicing, and recombinant soluble CD80 binds to CD28 and CD152 influencing T-cell activation.
Kakoulidou M; Giscombe R; Zhao X; Lefvert AK; Wang X
Scand J Immunol; 2007 Nov; 66(5):529-37. PubMed ID: 17953528
[TBL] [Abstract][Full Text] [Related]
17. CD5: a safeguard against autoimmunity and a shield for cancer cells.
Dalloul A
Autoimmun Rev; 2009 Feb; 8(4):349-53. PubMed ID: 19041428
[TBL] [Abstract][Full Text] [Related]
18. Multiple promoters regulate tissue-specific alternative splicing of the human kallikrein gene, KLK11/hippostasin.
Mitsui S; Nakamura T; Okui A; Kominami K; Uemura H; Yamaguchi N
FEBS J; 2006 Aug; 273(16):3678-86. PubMed ID: 16911518
[TBL] [Abstract][Full Text] [Related]
19. The paradox of CD5-expressing B cells in systemic lupus erythematosus.
Youinou P; Renaudineau Y
Autoimmun Rev; 2007 Dec; 7(2):149-54. PubMed ID: 18035326
[TBL] [Abstract][Full Text] [Related]
20. B-1 and B-2 B-cells in the pig cannot be differentiated by expression of CD5.
Wilson SM; Wilkie BN
Vet Immunol Immunopathol; 2007 Jan; 115(1-2):10-6. PubMed ID: 17098293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]